Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ketosis × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2099 Glioblastoma 1813 Glioma 1268 Central Nervous System Neoplasms 629 Astrocytoma 602 Neuroblastoma 585 Gliosarcoma 443 Oligodendroglioma 371 Neoplasms 369 Breast Neoplasms 297 Medulloblastoma 269 Carcinoma, Non-Small-Cell Lung 233 Meningioma 210 Recurrence 200 Sarcoma 194 Melanoma 185 Ependymoma 184 Neoplasm Metastasis 181 Lung Neoplasms 172 Neurofibromatosis 1 154 Lymphoma 144 Meningeal Carcinomatosis 126 Osteosarcoma 122 Ovarian Neoplasms 116 Wilms Tumor 115 Precursor Cell Lymphoblastic Leukemia-Lymphoma 110 Lymphoma, Non-Hodgkin 108 Diffuse Intrinsic Pontine Glioma 104 Head and Neck Neoplasms 101 Rhabdomyosarcoma 98

Interventions

Radiotherapy 1 Metformin 1 Hypoglycemic Agents 1 Diet, Carbohydrate-Restricted 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡